NATCO Pharma
Logotype for NATCO Pharma Limited

NATCO Pharma (NATCOPHARM) investor relations material

NATCO Pharma Q3 25/26 earnings summary

Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Logotype for NATCO Pharma Limited
Q3 25/26 earnings summary12 Feb, 2026

Executive summary

  • Q3 FY26 consolidated revenue reached INR 705.4 crore (INR 7,054 million), up from INR 651.1 crore year-over-year, with net profit at INR 151.3 crore (INR 1,513 million).

  • EBITDA for the quarter was INR 216.8 crore (INR 2,168 million), with a margin of 30.7%.

  • Board declared a third interim dividend of INR 1.5 per equity share for FY26.

  • Strategic acquisition of a 35.75% stake in Adcock Ingram Holdings, South Africa, completed for ZAR 3,873 million (USD 225 million).

  • Revenue growth driven by strong subsidiary performance in Brazil, Canada, the Middle East, and new product launches.

Financial highlights

  • Q3 FY26 total revenue: INR 7,054 million, up from INR 6,511 million in Q3 FY25.

  • PAT for Q3 FY26: INR 1,513 million, up from INR 1,324 million in Q3 FY25.

  • EPS for Q3 FY26: INR 8.46, up from INR 7.43 in Q3 FY25.

  • Subsidiary sales for Q3 were INR 177 crore out of total INR 705 crore.

  • Interim dividend of INR 1.5 per equity share declared.

Outlook and guidance

  • FY26 revenue expected to reach INR 4,300 crore, with PAT guidance of INR 1,280–1,300 crore.

  • Focus on expanding US product pipeline, with 30 Para IVs and over 20 FTFs, including 14 approved products.

  • Domestic business targeted to grow over 20% in FY26, mainly driven by semaglutide launch.

  • Guidance excludes significant Revlimid contribution.

  • Board granted in-principle approval to evaluate the demerger of the Agro Chemicals business.

Adcock PPA impact on future earnings?
Rationale for Agro chemicals demerger?
Chile subsidiary's market entry strategy?
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.

Next NATCO Pharma earnings date

Logotype for NATCO Pharma Limited
Q4 25/2626 May, 2026
NATCO Pharma
Your earnings 
season toolkit.
Download
Free on both iOS & Android.

Next NATCO Pharma earnings date

Logotype for NATCO Pharma Limited
Q4 25/2626 May, 2026

The essential earnings season companion

The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.

Live calls and transcripts

Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.

Find what you need faster

Search for any keyword across all transcripts simultaneously.

Easily store key findings

Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Your watchlist. Your dashboard.

Follow the companies that matter to you. Get a personalized feed with real-time updates.

Be the first to know

Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.

Consensus estimates

Access analyst consensus estimates, valuation multiples, and revenue segments splits.

All IR material in one place

The easiest way to stay updated during earnings season.

Global coverage

All events from public companies. Live and recorded.

Just click and listen

No webcast links. No manual registrations.

Research anytime, anywhere

Built for professionals. Loved by everyone. Try our free mobile app.

excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com

Frequently asked questions

NATCO Pharma Limited is a pharmaceutical company specializing in the development, manufacturing, and marketing of generic and specialty pharmaceuticals. The company produces a range of pharmaceutical products, including oncology, cardiology, and central nervous system medications, focusing on affordable therapies for complex health conditions. NATCO Pharma serves both domestic and international markets, providing formulations and active pharmaceutical ingredients (APIs) to healthcare providers and distributors. The company is headquartered in Hyderabad, India, and its shares are listed on the NSE and BSE.

Quartr provides global coverage of all investor relation material from public companies.

  • Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.

  • Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.

  • Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.

Yes, the Quartr mobile app is free on both iOS and Android.

Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.

Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.

Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.

Explore our global coverage